Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent PlasmaHyung Park, Eva Petkova, Dipyaman Ganguly et al.|JAMA Network Open|2022Cited by 66
COVID-19 reopening strategies at the county level in the face of uncertainty: Multiple Models for Outbreak Decision SupportKatriona Shea, Alexander N. Pillai, Rebecca K. Borchering et al.|medRxiv|2020Cited by 42
Multiple models for outbreak decision support in the face of uncertaintyKatriona Shea, Alexander N. Pillai, Rebecca K. Borchering et al.|Proceedings of the National Academy of Sciences|2023Cited by 41
Early administration of <scp>COVID</scp>‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacyArtur Belov, Peter Marks, Yin Huang et al.|American Journal of Hematology|2022Cited by 21